Cas:117519-07-0 3-Nitro-6-(trifluoromethyl)-2-pyridinol manufacturer & supplier

We serve Chemical Name:3-Nitro-6-(trifluoromethyl)-2-pyridinol CAS:117519-07-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Nitro-6-(trifluoromethyl)-2-pyridinol

Chemical Name:3-Nitro-6-(trifluoromethyl)-2-pyridinol
CAS.NO:117519-07-0
Synonyms:3-nitro-6-trifluoromethyl-2-pyridinone;3-Nitro-6-(trifluoromethyl)-2-pyridinol;2-Pyridinol, 3-nitro-6-(trifluoromethyl)-
Molecular Formula:C6H3F3N2O3
Molecular Weight:208.095
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:305.1±42.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.509
PSA:78.94000
Exact Mass:208.009583
LogP:1.59

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-nitro-6-trifluoromethyl-2-pyridinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyridinol, 3-nitro-6-(trifluoromethyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Nitro-6-(trifluoromethyl)-2-pyridinol Use and application,3-nitro-6-trifluoromethyl-2-pyridinone technical grade,usp/ep/jp grade.


Related News: While Stevanato has been in the headlines for its involvement in the fight against Covid-19—its factories immediately sprang to work producing vials and syringes for vaccines when Italy was still under lockdown in April 2020—vaccines only made up 4% of the company’s revenues in 2020 and 2019. (3-piperazin-1-yl-phenyl)-methanol manufacturers In 2018, the Bengaluru-based Natural Capsules set up an R&D centre in at Attibele, Bengaluru. In 2020, when PLI scheme was announced it applied for the same. 2,2,2-trichloro-N-(2-ethoxy-3-oxo-1,2,3,4-tetrahydrocyclopenta[b]indol-2-yl)acetamide suppliers The analysis examined disease manifestations in the two most commonly impacted organ domains in SLE. Anifrolumab is a potential first-in-class type I interferon inhibitor. 2,2′-diaminobiphenyl-1,4-bis(2-formylphenyl)-1,4-dithiabutanecopper(II) vendor & factory.